LifeScience Biologics

Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah

Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has sig...

 September 22, 2022 | News

Thermo Fisher unveils $160M bioprocessing facility in greater Boston

Thermo Fisher Scientific Inc., the world leader in serving science, today opened a new biomanufacturing facility in Chelmsford, Massachusetts. Th...

 September 21, 2022 | News

Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic Antibody-based Cell Therapy

Biocytogen’s TCR-mimic antibody development platform utilizes its proprietary fully human antibody RenMice™ (RenMab™ and RenLite®&nbs...

 September 19, 2022 | News

Juniper Biologics Establishes Global Headquarters in Singapore

Juniper Biologics, a science-led speciality healthcare company focused on commercialising novel therapies, today announced the establishment of its Global ...

 September 15, 2022 | News

Gilead Sciences Celebrates Top Ranking By Hepatitis and Asian Patient Groups

Gilead also ranks first among peers in Asia by patient groups in this region --     Gilead Sciences, Inc. ranks first among peers for over...

 September 15, 2022 | News

DLA Piper attends signing ceremony for exclusive strategic collaboration with Beijing E-town

Beijing E-town Bio Park is located in Beijing Economic and Technological Development Zone and has attracted close to 200 prestigious life science enterpris...

 September 13, 2022 | News

Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio

 The award will fund the continued advancement of the company's proprietary PANDAA™ technology platform and its specific application to the univ...

 September 13, 2022 | News

Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive early data for two novel and investigational bispecific antibodies – uba...

 September 12, 2022 | News

Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China

This is a phase I/IIa multi-center, open-label clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of anti-tumo...

 September 05, 2022 | News

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

 September 02, 2022 | News

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...

 September 01, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

 August 29, 2022 | News

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

 Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...

 August 29, 2022 | News

Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...

 August 25, 2022 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in